SC 13G

Company

Eloxx Pharmaceuticals, Inc.

Filed

May 29, 2018

Accession Number

0001178913-18-001762

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →